JCDC is a global, clinical-stage full service CRO. We provide end-to-end services for Phase I-IV Clinical Trials, Validation Studies, and Real World Evidence (RWE) Studies. Till date we have successfully executed 350+ clinical projects.

JCDC was formed in 2006 as a managed research centre within Jehangir Hospital, Pune. JCDC is one of the few research centres in India to be AAHRPP accredited, US FDA inspected and ISO 9001:2008 certified.

JCDC’s expertise is in
Medical Writing & Publications,
Regulatory Support (US FDA, EMEA, UK MHRA, TGA, PMDA, CDSCO, ASEAN and HSA),
Monitoring and Project Management,
Clinical Data Management,
Biostatistics and
Site Management.

Our expertise is in over 20 major therapeutic areas including Oncology, Psychiatry, Gastroenterology, Paediatrics, Orthopaedics, Neurology, Medicine, Infections, Respiratory, Gynaecology, Nutrition etc. Click to see Therapeutic Expertise our therapeutic indication wise expertise

We have a database of 200+ sites and 3,500 Investigators across India covering all major therapeutic areas. In addition to our database of sites in India we also work with partners in the US, Europe and Asia for global studies.

What makes us unique is our digital transformation and early adoption of decentralized clinical trials, which have allowed us to conduct clinical trials with minimum manual/paper processes and reduced the need for physical travel to sites. This results in significant cost and time savings for our clients.

Our multi-disciplinary team (including clinicians, researchers, regulatory and operational experts), hands-on approach, flexibility and complete transparency allows us to offer you customized solutions and study designs for your clinical trial’s success.

At JCDC, we try and maintain the highest level of ethics, integrity and transparency in our interactions with patients and in our relationships with our customers. Our focus is on offering premium quality services and our goal is to strive for excellence.

In essence, JCDC stands for Clinical Precision).